SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.80-0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (4938)11/29/1997 6:43:00 PM
From: Robert K.  Read Replies (2) of 17367
 
Ok so far. Now this trial is in itself a trial of bpis potential in this area. If it works for partial liver, it might work for other liver problems or even other surgerys (insults). Consider cirrohis or hepatitis. Now those are big markets. Will it work in partial hep.-We dont know. Will it work in cirrohsis or hepatitis. We really dont know. The significance is what if it does. Does that help?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext